Olfr539 Inhibitors
Olfr539, a member of the olfactory receptor family, stands at the forefront of olfactory signal transduction, playing a pivotal role in detecting specific odorants. This receptor contributes significantly to the intricate process of olfactory perception, where it serves as a molecular sensor, initiating cascades of events upon binding to its ligands. Functionally, Olfr539 is indispensable for the discrimination and interpretation of a diverse range of olfactory stimuli, allowing organisms to navigate and respond to their environment based on smell.
The inhibition of Olfr539 involves the targeted modulation of specific signaling pathways crucial for its activation. The inhibitors presented here act either directly on Olfr539 or indirectly by influencing parallel pathways linked to its function. For instance, inhibitors such as Rimonabant and GDC-0879 directly target endocannabinoid and MAPK pathways, respectively, disrupting Olfr539 activation by interfering with crucial protein-protein interactions and phosphorylation events. Indirect inhibitors like Wortmannin and SB-431542 modulate the PI3-kinase and TGF-beta pathways, respectively, altering the equilibrium of key molecules and suppressing Olfr539 activity indirectly by disrupting the interconnected signaling network. The diversity of mechanisms employed by these inhibitors underscores the complexity of Olfr539 inhibition and provides valuable insights into potential strategies for controlling olfactory signal transduction at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
CB1 receptor antagonist affecting the endocannabinoid pathway linked to Olfr539. Modulates intracellular signaling by inhibiting endocannabinoid binding, hindering downstream cascades crucial for Olfr539 function. | ||||||
GDC-0879 | 905281-76-7 | sc-364497 | 5 mg | $225.00 | ||
Selective BRAF inhibitor disrupting the MAPK pathway associated with Olfr539 activation. Interferes with phosphorylation events crucial for Olfr539 function, thereby hindering downstream signaling. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AKT kinase inhibitor selectively blocking a pathway associated with Olfr539 activation. Modulates cellular processes by impeding key intermediates, resulting in the suppression of Olfr539 activity. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $265.00 | ||
Selective ERK inhibitor of the ERK pathway associated with Olfr539 signaling cascade. Modulates cellular processes by impeding key intermediates, resulting in the suppression of Olfr539 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor selectively blocking a pathway associated with Olfr539 activation. Modulates cellular processes by impeding key intermediates, resulting in the suppression of Olfr539 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits the TGF-beta pathway influencing Olfr539 activation. Alters the equilibrium of key molecules, indirectly suppressing Olfr539 function by disrupting the interplay within the signaling network. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Modulates the JNK pathway crucial for Olfr539 activation. Alters the phosphorylation status of critical proteins, indirectly suppressing Olfr539 function by disrupting the interconnected signaling network. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Selectively inhibits the MEK pathway, leading to a cascade of events that suppress Olfr539 function. Alters the phosphorylation status of critical proteins to hinder downstream signaling. | ||||||
BKM120 | 944396-07-0 | sc-364437 sc-364437A sc-364437B sc-364437C | 5 mg 10 mg 25 mg 50 mg | $176.00 $235.00 $281.00 $339.00 | 9 | |
PI3-kinase inhibitor that disrupts the PI3-kinase pathway linked to Olfr539. Alters intracellular signaling by inhibiting PI3-kinase activity, hindering downstream cascades crucial for Olfr539 function. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $29.00 $82.00 $420.00 $1897.00 $3021.00 | 5 | |
Inhibits the MAPK pathway associated with Olfr539 activation. Interferes with phosphorylation events crucial for Olfr539 function, thereby hindering downstream signaling. | ||||||